Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Life Ark
AddedFeb 18, 2024
UpdatedJun 18, 2026
Life Ark

Life Ark

Seed

Zhongying Bio, a leading Chinese innovator in immune cell storage, R&D, and drug production.

HQ
Austin, TX, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize immune cell storage and application, Life Ark, also known as Zhongying Bio, is a pioneering Chinese company specializing in the research, development, and production of innovative cell drugs. The company focuses on large-scale preparation reagents for immune cells, particularly NK cells in vitro. By integrating R&D, production, and marketing, Life Ark aims to lead advancements in immune cell technology and provide cutting-edge solutions for medical treatments.

Life Ark boasts 35 invention patents, underscoring its position as an industry leader. The company has attracted notable investors and collaborators within the biotech sector, further solidifying its reputation. Life Ark's significant achievements include being one of the earliest immune cell research companies in China and maintaining a competitive edge through advanced technological innovations. Its impact is evident in the enhanced capabilities for immune cell storage and drug production, contributing to the broader field of medical science and patient care.

Life Ark - Similar Companies

Zhongyuan Union Cell & Gene Eng logo

Zhongyuan Union Cell & Gene Eng

Immunaeon logo

Immunaeon

immunaeon.com

Cellular Approaches logo

Cellular Approaches

Ark Biotech logo

Ark Biotech

BioLife Solutions logo

BioLife Solutions

Cell Vault logo

Cell Vault

cellvault.com

Larrk Bio logo

Larrk Bio

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

HebeCell logo

HebeCell

hebecellcorp.com

Celularity logo

Celularity

celularity.com

Acorn Biolabs logo

Acorn Biolabs

acorn.me

Legend Biotech logo

Legend Biotech

legendbiotech.com

ArsenalBio logo

ArsenalBio

arsenalbio.com

Arkin Bio Ventures logo

Arkin Bio Ventures

arkinholdings.com

Kincell Bio logo

Kincell Bio

kincellbio.com

Life Ark - Quick Facts

Who are Life Ark's competitors?

Companies similar to Life Ark include Zhongyuan Union Cell & Gene Eng, Immunaeon, Cellular Approaches and Ark Biotech.

When was Life Ark founded?

Life Ark was founded in 2017.

Where is Life Ark's headquarters located?

Life Ark's headquarters is located in Austin, TX, US.

How much has Life Ark raised to-date?

As of Feb 1, 2020, Life Ark has raised a total of $375k (USD).

How many employees does Life Ark have?

Life Ark has 30 employees as of Feb 4, 2024.

Life Ark - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • China
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapies
  • Drug Development
Tags
  • Healthcare
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software